Your browser doesn't support javascript.
loading
Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship." [Modern Pathology 34 (2021) 2154-2167].
Medeiros, L Jeffrey; Marques-Piubelli, Mario L; Sangiorgio, Valentina F I; Ruiz-Cordero, Roberto; Vega, Francisco; Feldman, Andrew L; Chapman, Jennifer R; Clemens, Mark W; Hunt, Kelly K; Evans, Mark G; Khoo, Christine; Lade, Stephen; Silberman, Mark; Morkowski, Jerzy; Pina, Edward M; Mills, Daniel C; Bates, Christopher M; Magno, Winston B; Sohani, Aliyah R; Sieling, Beth A; O'Donoghue, Joseph M; Bacon, Chris M; Patani, Neill; Televantou, Despina; Turner, Suzanne D; Johnson, Laura; MacNeill, Fiona; Wotherspoon, Andrew C; Iyer, Swaminathan P; Malpica, Luis E; Patel, Keyur P; Xu, Jie; Miranda, Roberto N.
  • Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sangiorgio VFI; Division of Hematopathology, Department of Cellular Pathology, The Royal London Hospital. Barts Health NSH Trust, London, United Kingdom.
  • Ruiz-Cordero R; Department of Pathology, University of California San Francisco, San Francisco, California.
  • Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Feldman AL; Division of Hematopathology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Chapman JR; Department of Pathology and Laboratory Medicine, University of Miami/Jackson Memorial Hospital, Miami, Florida.
  • Clemens MW; Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hunt KK; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Evans MG; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Khoo C; Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Lade S; Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Silberman M; Clinical Pathology Laboratory, Austin, Texas.
  • Morkowski J; MLD Pathology, Houston, Texas.
  • Pina EM; Pina Cosmetic Surgery, Department of Surgery, HCA Houston Healthcare Southeast, Houston, Texas.
  • Mills DC; Aesthetic Plastic Surgical Institute, Laguna Beach, California.
  • Bates CM; Ponte Vedra Plastic Surgery, Ponte Vedra Beach, Florida.
  • Magno WB; Regional Healthcare Associates, LLC, Waterbury, Connecticut.
  • Sohani AR; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Sieling BA; Department of Surgery, St. Mary's Hospital, Trinity Health of New England, Waterbury, Connecticut.
  • O'Donoghue JM; Department of Plastic Surgery, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
  • Bacon CM; Department of Cellular Pathology, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Patani N; Department of Breast Surgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Televantou D; Department of Cellular Pathology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
  • Turner SD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Johnson L; Department of Surgery, Barts Health NHS Trust, London, United Kingdom.
  • MacNeill F; Department of Surgery, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Wotherspoon AC; Department of Histopathology, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Iyer SP; Department of Myeloma and Lymphoma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Malpica LE; Department of Myeloma and Lymphoma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Miranda RN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: roberto.miranda@mdanderson.org.
Mod Pathol ; 36(12): 100355, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37948938
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article